Ayurcann Holdings Corp announced that it has entered into a medical education agreement with its third partner, Medical Cannabis Practitioners (MMJP), to offer Canadians education and support for medicinal cannabis.
The Ontario-based company said MMJP is led by Dr Hugh Mitchell, who has over 30 years of clinical experience with a dedicated staff of registered nurses. His interest in the association of cannabinoids with the human endocannabinoid system is a continuation of a specialized academic interest in neuroendocrine physiology, for which he obtained an MSc prior to his MD from Queen’s University, it added.
MMJP is supported by over 400 physicians and has served thousands of patients over the past seven years. The organization helps educate and integrate cannabis into patients’ medical plans and partners with medicinal cannabis providers such as Ayurcann, to ensure that patients are getting top-notch advice with exceptional value.
READ: Ayurcann enters into patient referral agreement for medical cannabis with The Herb Clinic
“Working closely with our partners in the industry is what we believe will distinguish Ayurcann in the long term and being able to partner with cannabis education providers will provide the best value on a national platform, expanding our reach, our name and our offerings for THC and CBD-based products to patients,” Ayurcann CEO Igal Sudman said in a statement.
Ayurcann is a leading post-harvest solution provider with a focus on providing and creating custom processes and pharma-grade products for the adult-use and medical cannabis industry in Canada.
It is focused on becoming the partner of choice for leading Canadian cannabis brands by providing best-in-class, proprietary services including ethanol extraction, formulation, product development, and custom manufacturing.
Contact the author at stephen.gunnion@proactiveinvestors.com